Assessment of Healthcare Professionals’ Knowledge and Understanding of the Risk of Blood Typing Interference With Daratumumab: A Survey of 12 European Countries
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).